Johnson & Johnson Explores $20 Billion Sale of Orthopedics Unit

Johnson & Johnson, a multinational healthcare company, is reportedly exploring the sale of its orthopedics unit for approximately $20 billion. According to a source, the company is seeking to divest the unit as part of its efforts to focus on its core businesses.

The orthopedics unit, which includes brands such as DePuy Synthes and Codman, has been a significant contributor to Johnson & Johnson's revenue in recent years. However, the company has been facing increased competition in the orthopedics market, and the sale of the unit could help it to reduce its debt and focus on its more profitable businesses.

The sale of the orthopedics unit is still in its early stages, and it is unclear whether Johnson & Johnson will be able to find a buyer for the unit at the desired price. However, the company's decision to explore the sale of the unit is a significant development in the healthcare industry, and it could have implications for the future of the orthopedics market.

Sources

[2] Johnson & Johnson explores $20 billion sale of orthopedics unit, source says